Zongyang Yu

534 total citations
21 papers, 298 citations indexed

About

Zongyang Yu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zongyang Yu has authored 21 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zongyang Yu's work include Epigenetics and DNA Methylation (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Zongyang Yu is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Zongyang Yu collaborates with scholars based in China, United States and Italy. Zongyang Yu's co-authors include Ying Chen, Ying Chen, Xiaoyan Qi, Xiangyang Dou, Lei Zhang, Qiang Xu, Shuiliang Wang, Fan Yang, Srikrishnan Siva Subramanian and Xuanmei Fan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and The Oncologist.

In The Last Decade

Zongyang Yu

19 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongyang Yu China 11 132 94 85 81 43 21 298
Hailong Shi China 11 86 0.7× 54 0.6× 105 1.2× 48 0.6× 30 0.7× 23 315
Qinghua Qi China 10 103 0.8× 29 0.3× 48 0.6× 77 1.0× 5 0.1× 32 334
Wu Ju China 9 166 1.3× 24 0.3× 30 0.4× 117 1.4× 6 0.1× 39 330
Fengkai Li China 11 147 1.1× 30 0.3× 147 1.7× 63 0.8× 28 0.7× 17 360
Xiaojuan Pan China 12 315 2.4× 45 0.5× 69 0.8× 203 2.5× 33 0.8× 28 487
Yiran Niu China 9 88 0.7× 45 0.5× 91 1.1× 56 0.7× 4 0.1× 17 343
Massimo Melis Italy 8 18 0.1× 55 0.6× 28 0.3× 45 0.6× 9 0.2× 9 234
Olga V. Krymskaya Russia 4 242 1.8× 65 0.7× 65 0.8× 57 0.7× 2 0.0× 6 486
Yang Wen China 12 456 3.5× 22 0.2× 41 0.5× 358 4.4× 5 0.1× 30 735

Countries citing papers authored by Zongyang Yu

Since Specialization
Citations

This map shows the geographic impact of Zongyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongyang Yu more than expected).

Fields of papers citing papers by Zongyang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongyang Yu. The network helps show where Zongyang Yu may publish in the future.

Co-authorship network of co-authors of Zongyang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zongyang Yu. A scholar is included among the top collaborators of Zongyang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongyang Yu. Zongyang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zongyang, et al.. (2025). CPT1A promotes the proliferation and immune evasion of lung cancer by inducing CTLA-4 K154 succinylation. Biochemical and Biophysical Research Communications. 780. 152488–152488.
2.
Yu, Zongyang, et al.. (2024). USP8‐mediated PTK7 promotes PIK3CB‐related pathway to accelerate the malignant progression of non‐small cell lung cancer. Thoracic Cancer. 16(1). e15485–e15485. 1 indexed citations
3.
Luο, Xingguang, Ying Chen, Ping Lin, et al.. (2024). Construction of a risk prediction model for isolated pulmonary nodules 5–15 mm in diameter. Translational Lung Cancer Research. 13(11). 3139–3151. 1 indexed citations
4.
Lin, Ping, Lei Zhang, Arthur Yin Fan, et al.. (2024). Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative review. Translational Cancer Research. 13(2). 1166–1187. 7 indexed citations
5.
Ye, Jia, Lei Zhang, Zongyang Yu, et al.. (2024). CDT1, transcriptionally regulated by E2F2, promotes lung adenocarcinoma progression. Heliyon. 10(16). e36557–e36557.
6.
Chen, Meiyan, Qing Wang, Huijuan Wang, et al.. (2023). Comparison of different therapeutic approaches for pulmonary cryptococcosis in kidney transplant recipients: a 15-year retrospective analysis. Frontiers in Medicine. 10. 1107330–1107330. 1 indexed citations
7.
Zhang, Lei, et al.. (2022). Cancer cell-derived exosomal LINC00313 induces M2 macrophage differentiation in non-small cell lung cancer. Clinical & Translational Oncology. 24(12). 2395–2408. 27 indexed citations
8.
9.
10.
Liu, Wei, Yabin Zhang, Chengzhi Zhou, et al.. (2021). Pneumonia caused by Talaromyces marneffei in an epidermal growth factor receptor (EGFR) mutation-positive advanced lung adenocarcinoma patient: a case report. Annals of Palliative Medicine. 10(1). 759–766. 4 indexed citations
11.
Song, Li, et al.. (2021). CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway. Frontiers in Oncology. 10. 577229–577229. 32 indexed citations
12.
Yang, Fan, Xuanmei Fan, Srikrishnan Siva Subramanian, et al.. (2021). Catastrophic debris flows triggered by the 20 August 2019 rainfall, a decade since the Wenchuan earthquake, China. Landslides. 18(9). 3197–3212. 46 indexed citations
13.
Yu, Zongyang, Tao Huang, Dan Hu, et al.. (2020). The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/Stat 5/β-Catenin Signaling Pathway. Frontiers in Oncology. 10. 585292–585292. 8 indexed citations
14.
Wu, Xiaoli, et al.. (2020). Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report. Frontiers in Oncology. 10. 565945–565945. 19 indexed citations
15.
Yu, Zongyang, Xiuyu Cai, Zhiyong He, et al.. (2020). Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial. The Oncologist. 25(11). e1640–e1649. 11 indexed citations
16.
Wu, Xiaoli, Xiaoyan Qi, Shuiliang Wang, et al.. (2019). Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway. Life Sciences. 239. 116879–116879. 30 indexed citations
17.
Lei, Lei, Wenxian Wang, Zongyang Yu, et al.. (2019). A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations. Translational Oncology. 13(2). 329–335. 25 indexed citations
18.
Ren, Qun, Rong Lin, Hu Zhao, et al.. (2019). Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs. Journal of Experimental & Clinical Cancer Research. 38(1). 150–150. 31 indexed citations
19.
Yu, Zongyang, et al.. (2014). Expression of XIAP and Smac in human non-small-cell lung carcinoma(NSCLC)and the relationship with clinical significance and prognosis. 41(7). 444–448. 1 indexed citations
20.
Xie, Fangwei, Xi Chen, Xiong Chen, et al.. (2014). Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11. Biomedicine & Pharmacotherapy. 68(7). 825–831. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hailong Shi Breakdown of academic impact, for papers by Qinghua Qi Breakdown of academic impact, for papers by Wu Ju Breakdown of academic impact, for papers by Fengkai Li Breakdown of academic impact, for papers by Xiaojuan Pan Breakdown of academic impact, for papers by Yiran Niu Breakdown of academic impact, for papers by Massimo Melis Breakdown of academic impact, for papers by Olga V. Krymskaya Breakdown of academic impact, for papers by Yang Wen
Rankless by CCL
2026